FDA Approved: LEVETIRACETAM — Original Application (ScieGen Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved the original application (ANDA) for LEVETIRACETAM by ScieGen Pharmaceuticals, authorizing the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Generalized Tonic-clonic Seizures
• Idiopathic Generalized Epilepsy
• Juvenile Myoclonic Epilepsy
• Myoclonic Seizures
• Partial-onset Seizures

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

ORIG AP for LEVETIRACETAM (LEVETIRACETAM)